HIV virus |
, - , .
- :
An experimental HIV vaccine has for the first time cut the risk of infection, researchers say.
The vaccine a combination of two earlier experimental vaccines was given to 16,000 people in Thailand, in the largest ever such vaccine trial.
Researchers found that it reduced by nearly a third the risk of contracting HIV, the virus that leads to Aids.
It has been hailed as a significant, scientific breakthrough, but a global vaccine is still some way off.
